Condition: Respiratory Syncytial Virus · Sponsor: ModernaTX, Inc.
The main purpose of Part A of this study is to evaluate the safety and tolerability of mRNA-1345 vaccine and to demonstrate the efficacy of a single dose of mRNA-1345 vaccine in the prevention of a first episode of RSV-associated lower respiratory tract disease (RSV-LRTD) as compared with placebo from 14 days postinjection through 12 months. The main purpose of Part B of this study is to evaluate the safety, tolerability and immunogenicity of a booster dose (BD) of mRNA-1345 administered 24 months after the primary dose.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| AES - DRS - Synexus Clinical Research US, Inc. - Birmingham | Birmingham, Alabama, United States | — |
| Accel Research Site - Achieve - Birmingham | Birmingham, Alabama, United States | — |
| Lakeview Clinical Research | Guntersville, Alabama, United States | — |
| AES - DRS - Optimal Research Alabama - Huntsville | Huntsville, Alabama, United States | — |
| Hope Research Institute LLC - Hunt - PPDS | Hunt, Arizona, United States | — |
| Hope Research Institute LLC - Hunt - PPDS | Hunt, Arizona, United States | — |
| Desert Clinical Research, LLC - CCT | Mesa, Arizona, United States | — |
| Hope Research Institute LLC - Phoenix - Hunt - PPDS | Phoenix, Arizona, United States | — |
| AES - DRS - Synexus Clinical Research US, Inc. - Phoenix Central | Phoenix, Arizona, United States | — |
| Synexus Clinical Research US, Inc. - Phoenix Southeast | Phoenix, Arizona, United States | — |
| Tucson Neuroscience Research - M3 WR | Tucson, Arizona, United States | — |
| Baptist Health Center for Clinical Research | Little Rock, Arkansas, United States | — |
+ 257 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05127434